Niels Jongs Selected Research

Niels Jongs Research Topics

Disease

31	Chronic Renal Insufficiency 02/2024 - 01/2021
30	Type 2 Diabetes Mellitus (MODY) 02/2024 - 01/2021
14	Renal Insufficiency (Renal Failure) 12/2023 - 01/2021
12	Albuminuria 02/2024 - 01/2021
7	Heart Failure 01/2023 - 01/2021
4	Kidney Diseases (Kidney Disease) 12/2023 - 11/2021
3	Hyperkalemia 12/2023 - 01/2022
2	Chronic Kidney Failure (Chronic Renal Failure) 11/2023 - 01/2021
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2023 - 01/2023
2	Neoplasms (Cancer) 01/2023 - 01/2021
2	Body Weight (Weight, Body) 01/2023 - 01/2022
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023 - 01/2021
2	Glomerulonephritis 01/2021 - 01/2021
1	Pain (Aches) 12/2023
1	Inflammation (Inflammations) 11/2023
1	Frailty 08/2023
1	Anemia 06/2023
1	Nutrition Disorders (Nutritional Disorders) 01/2023
1	Heart Diseases (Heart Disease) 01/2023
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2022
1	Obesity 01/2022
1	Overweight 01/2022
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2021
1	Depressive Disorder (Melancholia) 01/2021
1	Prediabetic State (Prediabetes) 01/2021
1	Infections 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021

Drug/Important Bio-Agent (IBA)

32	dapagliflozinIBA 02/2024 - 01/2021
15	AlbuminsIBA 01/2024 - 11/2021
15	CreatinineIBA 01/2024 - 11/2021
8	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2023 - 11/2021
7	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 01/2022
6	SodiumIBA 11/2023 - 01/2022
4	CanagliflozinIBA 12/2023 - 01/2022
3	Sodium-Glucose Transport ProteinsIBA 02/2024 - 01/2021
3	AtrasentanIBA 12/2023 - 01/2023
3	Eplerenone (Inspra)FDA LinkGeneric 11/2023 - 01/2022
3	Mineralocorticoid Receptor AntagonistsIBA 11/2023 - 03/2022
3	baricitinibIBA 11/2023 - 01/2023
3	LinagliptinIBA 11/2023 - 01/2023
3	empagliflozinIBA 11/2023 - 01/2023
3	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2021
3	Telmisartan (Micardis)FDA Link 11/2023 - 01/2023
2	finerenoneIBA 12/2023 - 01/2023
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2023 - 12/2022
2	Angiotensin Receptor AntagonistsIBA 12/2023 - 12/2022
2	Hemoglobins (Hemoglobin)IBA 11/2023 - 01/2022
2	SymportersIBA 11/2023 - 11/2023
1	Endothelin Receptor AntagonistsIBA 12/2023
1	HCEIBA 12/2023
1	aliskiren FDA Link 12/2023
1	Irbesartan FDA LinkGeneric 12/2023
1	Analgesics (Analgesic Drugs)IBA 12/2023
1	Opioid Analgesics (Opioids)IBA 12/2023
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2023
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2023
1	Endothelin-1 (Endothelin 1)IBA 12/2023
1	Losartan (Cozaar)FDA LinkGeneric 12/2023
1	Ferritins (Ferritin)IBA 11/2023
1	IronIBA 11/2023
1	saxagliptin FDA Link 11/2023
1	Urokinase Plasminogen Activator ReceptorsIBA 11/2023
1	LithiumIBA 01/2023
1	Exenatide (Byetta)FDA Link 01/2023
1	benazepril (Briem)FDA LinkGeneric 12/2022
1	Spironolactone (Aldactone)FDA LinkGeneric 03/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Immunoglobulin A (IgA)IBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021

Therapy/Procedure

6	Therapeutics 12/2023 - 01/2022
1	Glycemic Control 01/2023
1	Kidney Transplantation 01/2022
1	Secondary Prevention 01/2021